CCA
MSOS icon

Cravens & Co Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Cravens & Co Advisors’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,818
Closed -$63.3K – 73
2026
Q1 		$63.3K Hold
17,818
– – 0.04% 63
2025
Q4 		$85.7K Buy
17,818
+850
+5% +$3.79K 0.06% 62
2025
Q3 		$81.3K Hold
16,968
– – 0.06% 57
2025
Q2 		$40.9K Buy
16,968
+1,780
+12% +$4.38K 0.03% 55
2025
Q1 		$39.6K Sell
15,188
-13,258
-47% -$42.8K 0.03% 57
2024
Q4 		$108K Sell
28,446
-20,062
-41% -$108K 0.08% 60
2024
Q3 		$348K Sell
48,508
-945
-2% -$6.71K 0.27% 48
2024
Q2 		$362K Hold
49,453
– – 0.27% 53
2024
Q1 		$495K Sell
49,453
-1,178
-2% -$10.3K 0.41% 45
2023
Q4 		$355K Sell
50,631
-435
-0.9% -$2.89K 0.31% 53
2023
Q3 		$405K Buy
51,066
+178
+0.3% +$1.12K 0.38% 48
2023
Q2 		$282K Buy
50,888
+19,930
+64% +$109K 0.26% 64
2023
Q1 		$176K Buy
30,958
+1,599
+5% +$10.6K 0.16% 71
2022
Q4 		$205K Buy
+29,359
New +$302K 0.19% 75

Other funds holding MSOS

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Cravens & Co Advisors's MSOS Position: Q2 2026 in Review

Cravens & Co Advisors sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2026, closing a stake of 17,818 shares — an estimated $63.3K sold.

Cravens & Co Advisors first reported a position in MSOS in Q4 2022 and held it in 14 quarters. The position peaked at $495K in Q1 2024. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Cravens & Co Advisors reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2026 after selling out during the quarter.
  • Cravens & Co Advisors sold 17,818 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $63.3K.
  • Cravens & Co Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and held it in 14 quarters.
  • Cravens & Co Advisors's AdvisorShares Pure US Cannabis ETF position peaked at $495K in Q1 2024.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Cravens & Co Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.